Literature DB >> 16958857

Identification of a Francisella tularensis LVS outer membrane protein that confers adherence to A549 human lung cells.

Amanda Melillo1, Darren D Sledjeski, Serena Lipski, Ronald Mark Wooten, Venkatesha Basrur, Eric R Lafontaine.   

Abstract

Francisella tularensis is a highly pathogenic bacterium; however, little is known about its initial interactions with mucosal surfaces of the human respiratory tract. To investigate these interactions, we tested whether two Francisella strains could adhere to A549 human lung epithelial cells. We found that LVS adhered well to these cells while Francisella novicida adhered poorly. We used surface biotinylation to identify bacterial proteins that might mediate this adherence. We report the identification of the F. tularensis surface protein FsaP, which, when expressed in nonadherent Escherichia coli, confers recombinant bacteria with the ability to bind to A549 cells.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 16958857     DOI: 10.1111/j.1574-6968.2006.00413.x

Source DB:  PubMed          Journal:  FEMS Microbiol Lett        ISSN: 0378-1097            Impact factor:   2.742


  31 in total

1.  BcsKC is an essential protein for the type VI secretion system activity in Burkholderia cenocepacia that forms an outer membrane complex with BcsLB.

Authors:  Daniel Aubert; Douglas K MacDonald; Miguel A Valvano
Journal:  J Biol Chem       Date:  2010-08-20       Impact factor: 5.157

2.  The biochemical properties of the Francisella pathogenicity island (FPI)-encoded proteins IglA, IglB, IglC, PdpB and DotU suggest roles in type VI secretion.

Authors:  Olle M de Bruin; Barry N Duplantis; Jagjit S Ludu; Rebekah F Hare; Eli B Nix; Crystal L Schmerk; Craig S Robb; Alisdair B Boraston; Karsten Hueffer; Francis E Nano
Journal:  Microbiology (Reading)       Date:  2011-10-06       Impact factor: 2.777

3.  TolC-dependent modulation of host cell death by the Francisella tularensis live vaccine strain.

Authors:  Christopher R Doyle; Ji-An Pan; Patricio Mena; Wei-Xing Zong; David G Thanassi
Journal:  Infect Immun       Date:  2014-03-10       Impact factor: 3.441

4.  Generation and characterization of hybridoma antibodies for immunotherapy of tularemia.

Authors:  Zhaohua Lu; Marly I Roche; Julia H Hui; Berkay Unal; Philip L Felgner; Sunita Gulati; Guillermo Madico; Jacqueline Sharon
Journal:  Immunol Lett       Date:  2007-08-08       Impact factor: 3.685

5.  Francisella tularensis infection-derived monoclonal antibodies provide detection, protection, and therapy.

Authors:  Anne G Savitt; Patricio Mena-Taboada; Gloria Monsalve; Jorge L Benach
Journal:  Clin Vaccine Immunol       Date:  2009-01-28

6.  Contributions of Francisella tularensis subsp. novicida chitinases and Sec secretion system to biofilm formation on chitin.

Authors:  Jeffrey J Margolis; Sahar El-Etr; Lydia-Marie Joubert; Emily Moore; Richard Robison; Amy Rasley; Alfred M Spormann; Denise M Monack
Journal:  Appl Environ Microbiol       Date:  2009-11-30       Impact factor: 4.792

7.  Type IV pili in Francisella tularensis: roles of pilF and pilT in fiber assembly, host cell adherence, and virulence.

Authors:  Subhra Chakraborty; Michael Monfett; Tamara M Maier; Jorge L Benach; Dara W Frank; David G Thanassi
Journal:  Infect Immun       Date:  2008-04-21       Impact factor: 3.441

8.  Francisella tularensis invasion of lung epithelial cells.

Authors:  Robin R Craven; Joshua D Hall; James R Fuller; Sharon Taft-Benz; Thomas H Kawula
Journal:  Infect Immun       Date:  2008-04-21       Impact factor: 3.441

9.  Francisella tularensis genes required for inhibition of the neutrophil respiratory burst and intramacrophage growth identified by random transposon mutagenesis of strain LVS.

Authors:  Grant S Schulert; Ramona L McCaffrey; Blake W Buchan; Stephen R Lindemann; Clayton Hollenback; Bradley D Jones; Lee-Ann H Allen
Journal:  Infect Immun       Date:  2009-02-09       Impact factor: 3.441

10.  Antioxidant Defenses of Francisella tularensis Modulate Macrophage Function and Production of Proinflammatory Cytokines.

Authors:  Seham M Rabadi; Belkys C Sanchez; Mrudula Varanat; Zhuo Ma; Sally V Catlett; Juan Andres Melendez; Meenakshi Malik; Chandra Shekhar Bakshi
Journal:  J Biol Chem       Date:  2015-12-07       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.